The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Treatment with 5-Fluorouracil/Folinic Acid, Oxaliplatin, and Irinotecan Enables Surgical Resection of Metastases in Patients With Initially Unresectable Metastatic Colorectal Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grothey, A., Sargent, D., Goldberg, R. M., & Schmoll, H.-J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.037 · Cited by 1,070 · cited 1×
“Once the new active drugs irinotecan and oxaliplatin were introduced and combined with 5-FU in the firstline treatment of metastatic disease, the objective response rate increased to 40% to 50%, and the median survival increased to 17 to 21 months.(12) In addition, the availability of highly active chemotherapy regime…”
BackgroundSurgical treatment for both pulmonary and hepatic metastases from colorectal cancer
Kobayashi, K., Kawamura, M., & Ishihara, T. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70106-6 · Cited by 152
Cited by
Falcone, A., Ricci, S., Brunetti, I., Pfanner, E., Allegrini, G., Barbara, C., Crinò, L., Benedetti, G., Evangelista, W., Fanchini, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0928 · Cited by 1,241
“The 4-year survival of these patients was 37%.(16) On the basis of these results, the Gruppo Oncologico Nord Ovest (GONO) launched a phase III randomized trial to compare the simplified FOLFOXIRI regimen to a standard combination of FU/LV and CPT-11 (FOLFIRI) that had demonstrated improved efficacy in comparison to FU…”
Self-citationPatients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?
Adam, R., Wicherts, D. A., de Haas, R. J., Ciacio, O., Lévi, F., Paule, B., Ducreux, M., Azoulay, D., Bismuth, H., & Castaing, D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9273 · Cited by 590
Long-Term Results of Two-Stage Hepatectomy for Irresectable Colorectal Cancer Liver Metastases
Wicherts, D. A., Miller, R., de Haas, R. J., Bitsakou, G., Vibert, E., Veilhan, L.-A., Azoulay, D., Bismuth, H., Castaing, D., & Adam, R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181907fd9 · Cited by 332
Nordlinger, B., Van Cutsem, E., Rougier, P., Köhne, C.-H., Ychou, M., Sobrero, A., Adam, R., Arvidsson, D., Carrato, A., Georgoulias, V., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.017 · Cited by 272
Metadata
- Authors
- Masi, G., Cupini, S., Marcucci, L., Cerri, E., Loupakis, F., Allegrini, G., Brunetti, I. M., Pfanner, E., Viti, M., Goletti, O., Filipponi, F., & Falcone, A.
- Venue
- Annals of Surgical Oncology
- Published
- 2006-01
- Volume
- 13
- Issue
- 1
- Pages
- 58-65
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W2070779199
- Cited by
- 162
- References
- 2
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.